Janssen develops treatments for some of the most devastating disorders and complex medical challenges of our times, including cancer, hepatitis, HIV/AIDS, diabetes, arthritis, dementia, and mental disorders. We focus our research on five strategic pathological areas: oncology, neurosciences, infectious diseases and vaccines, immunology, and cardiovascular and metabolic disorders.
Dr. Paul Janssen founded the company in 1953 with only one thing in mind: saving people’s lives thanks to the development of better medicines. In 1961, the company affiliated with the Johnson & Johnson Group, global market leader in healthcare products. The group has more than 265 operational companies in 60 countries today and more than 128,000 employees worldwide.
Quick facts about Janssen in Baltic Countries:
- We employ around 40 people in Estonia, Latvia and Lithuania
- Our offices in Tallinn, Riga and Vilnius:
UAB “JOHNSON & JOHNSON” Eesti filiaal Lõõtsa str. 2 EE-11415 Tallinn, Estonia |
UAB “JOHNSON & JOHNSON” filiāle Latvijā Mukusalas str. 101 LV-1004 Riga, Latvia |
UAB “JOHNSON & JOHNSON” Konstitucijos av. 21C, Vilnius, QUADRUM business center north, 5th floor LT-08130 Lithuania Tel +370 5 278 6888 Fax +370 5 278 6889 |
- We are driven by the J&J Credo, which was founded in 1943 by Robert Wood
- Johnson Our Credo challenges us to put the needs and well-being of the people we serve first